6-arylalkylamino2,3,4,5-tetrahydro-1H-benzo(d)azepine s as 5-HT2c receptor agonists

Details for Australian Patent Application No. 2006287202 (hide)

Owner Eli Lilly and Company

Inventors Reinhard, Matthew Robert; Williams, Andrew Caerwyn; O'Toole, John Cunningham; Briner, Karin; Mazanetz, Michael Philip; Sapmaz, Selma; Adeva Bartolome, Marta; Cases-Thomas, Manuel Javier; Martinez-Grau, Maria Angeles; Marcos Llorente, Alicia; Galka, Christopher Stanley; Rathmell, Richard Edmund

Agent Spruson & Ferguson

Pub. Number AU-A-2006287202

PCT Pub. Number WO2007/028083

Priority 60/731,081 28.10.05 US; 05380191.6 01.09.05 EP

Filing date 1 September 2006

Wipo publication date 8 March 2007

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/028083 Priority application(s): WO2007/028083

13 March 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Eli Lilly and Company, Application No. 2006287202, Under INID (54), correct the title to 6-arylalkylamino2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287207-Methods for enhancing the dewaterability of sludge with alpha-amylase treatment

2006287197-Method of repairing meniscal tears